These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33439866)

  • 21. Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up.
    Koenig W; Breitling LP; Hahmann H; Wüsten B; Brenner H; Rothenbacher D
    Clin Chem; 2012 Aug; 58(8):1215-24. PubMed ID: 22634379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discovery of new biomarkers for atrial fibrillation using a custom-made proteomics chip.
    Lind L; Sundström J; Stenemo M; Hagström E; Ärnlöv J
    Heart; 2017 Mar; 103(5):377-382. PubMed ID: 27609943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study.
    Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T
    Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth differentiation factor 15 predicts cardiovascular events in stable coronary artery disease.
    Wang J; Han LN; Ai DS; Wang XY; Zhang WJ; Xu XR; Liu HB; Zhang J; Wang P; Li X; Chen ML
    J Geriatr Cardiol; 2023 Jul; 20(7):527-537. PubMed ID: 37576485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study.
    Zewinger S; Kleber ME; Tragante V; McCubrey RO; Schmidt AF; Direk K; Laufs U; Werner C; Koenig W; Rothenbacher D; Mons U; Breitling LP; Brenner H; Jennings RT; Petrakis I; Triem S; Klug M; Filips A; Blankenberg S; Waldeyer C; Sinning C; Schnabel RB; Lackner KJ; Vlachopoulou E; Nygård O; Svingen GFT; Pedersen ER; Tell GS; Sinisalo J; Nieminen MS; Laaksonen R; Trompet S; Smit RAJ; Sattar N; Jukema JW; Groesdonk HV; Delgado G; Stojakovic T; Pilbrow AP; Cameron VA; Richards AM; Doughty RN; Gong Y; Cooper-DeHoff R; Johnson J; Scholz M; Beutner F; Thiery J; Smith JG; Vilmundarson RO; McPherson R; Stewart AFR; Cresci S; Lenzini PA; Spertus JA; Olivieri O; Girelli D; Martinelli NI; Leiherer A; Saely CH; Drexel H; Mündlein A; Braund PS; Nelson CP; Samani NJ; Kofink D; Hoefer IE; Pasterkamp G; Quyyumi AA; Ko YA; Hartiala JA; Allayee H; Tang WHW; Hazen SL; Eriksson N; Held C; Hagström E; Wallentin L; Åkerblom A; Siegbahn A; Karp I; Labos C; Pilote L; Engert JC; Brophy JM; Thanassoulis G; Bogaty P; Szczeklik W; Kaczor M; Sanak M; Virani SS; Ballantyne CM; Lee VV; Boerwinkle E; Holmes MV; Horne BD; Hingorani A; Asselbergs FW; Patel RS; ; Krämer BK; Scharnagl H; Fliser D; März W; Speer T
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):534-543. PubMed ID: 28566218
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers in stable coronary heart disease, their modulation and cardiovascular risk: The LIPID biomarker study.
    Tonkin AM; Blankenberg S; Kirby A; Zeller T; Colquhoun DM; Funke-Kaiser A; Hague W; Hunt D; Keech AC; Nestel P; Stewart R; Sullivan DR; Thompson PL; West M; White HD; Simes J;
    Int J Cardiol; 2015 Dec; 201():499-507. PubMed ID: 26318511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hs-cTroponins for the prediction of recurrent cardiovascular events in patients with established CHD - A comparative analysis from the KAROLA study.
    Jansen H; Jänsch A; Breitling LP; Hoppe L; Dallmeier D; Schmucker R; Brenner H; Koenig W; Rothenbacher D
    Int J Cardiol; 2018 Jan; 250():247-252. PubMed ID: 29169757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Circulating Metabolites With Risk of Coronary Heart Disease in a European Population: Results From the Biomarkers for Cardiovascular Risk Assessment in Europe (BiomarCaRE) Consortium.
    Cavus E; Karakas M; Ojeda FM; Kontto J; Veronesi G; Ferrario MM; Linneberg A; Jørgensen T; Meisinger C; Thorand B; Iacoviello L; Börnigen D; Woodward M; Schnabel R; Costanzo S; Tunstall-Pedoe H; Koenig W; Kuulasmaa K; Salomaa V; Blankenberg S; Zeller T;
    JAMA Cardiol; 2019 Dec; 4(12):1270-1279. PubMed ID: 31664431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of Fibroblast Growth Factor 23 With Risk of Incident Coronary Heart Disease in Community-Living Adults.
    Panwar B; Judd SE; Wadley VG; Jenny NS; Howard VJ; Safford MM; Gutiérrez OM
    JAMA Cardiol; 2018 Apr; 3(4):318-325. PubMed ID: 29516098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osteoprotegerin Is Associated With Major Bleeding But Not With Cardiovascular Outcomes in Patients With Acute Coronary Syndromes: Insights From the PLATO (Platelet Inhibition and Patient Outcomes) Trial.
    Ueland T; Åkerblom A; Ghukasyan T; Michelsen AE; Aukrust P; Becker RC; Bertilsson M; Himmelmann A; James SK; Siegbahn A; Storey RF; Kontny F; Wallentin L;
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29330256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Plasma Testosterone Is Associated With Elevated Cardiovascular Disease Biomarkers.
    Pastuszak AW; Kohn TP; Estis J; Lipshultz LI
    J Sex Med; 2017 Sep; 14(9):1095-1103. PubMed ID: 28757119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease.
    Nozaki T; Sugiyama S; Koga H; Sugamura K; Ohba K; Matsuzawa Y; Sumida H; Matsui K; Jinnouchi H; Ogawa H
    J Am Coll Cardiol; 2009 Aug; 54(7):601-8. PubMed ID: 19660689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frontal plane T-wave axis orientation predicts coronary events: Findings from the Moli-sani study.
    Iacoviello L; Bonaccio M; Di Castelnuovo A; Costanzo S; Rago L; De Curtis A; Assanelli D; Badilini F; Vaglio M; Persichillo M; Macfarlane PW; Cerletti C; Donati MB; de Gaetano G;
    Atherosclerosis; 2017 Sep; 264():51-57. PubMed ID: 28772106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation.
    Hijazi Z; Wallentin L; Lindbäck J; Alexander JH; Connolly SJ; Eikelboom JW; Ezekowitz MD; Granger CB; Lopes RD; Pol T; Yusuf S; Oldgren J; Siegbahn A
    J Am Heart Assoc; 2020 Dec; 9(24):e018984. PubMed ID: 33292046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.
    Carlsson AC; Ruge T; Kjøller E; Hilden J; Kolmos HJ; Sajadieh A; Kastrup J; Jensen GB; Larsson A; Nowak C; Jakobsen JC; Winkel P; Gluud C; Ärnlöv J
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
    Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
    Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease-a comparison in the MONICA/KORA study.
    Huth C; Bauer A; Zierer A; Sudduth-Klinger J; Meisinger C; Roden M; Peters A; Koenig W; Herder C; Thorand B
    Cardiovasc Diabetol; 2020 Mar; 19(1):32. PubMed ID: 32164753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease.
    Stewart RAH; Hagström E; Held C; Wang TKM; Armstrong PW; Aylward PE; Cannon CP; Koenig W; López-Sendón JL; Mohler ER; Hadziosmanovic N; Krug-Gourley S; Ramos Corrales MA; Siddique S; Steg PG; White HD; Wallentin L;
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copeptin, B-type natriuretic peptide and cystatin C are associated with incident symptomatic PAD.
    Fatemi S; Acosta S; Gottsäter A; Melander O; Engström G; Dakhel A; Zarrouk M
    Biomarkers; 2019 Sep; 24(6):615-621. PubMed ID: 31215249
    [No Abstract]   [Full Text] [Related]  

  • 40. High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.
    Koenig W
    Int J Cardiol; 2013 Oct; 168(6):5126-34. PubMed ID: 23978367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.